SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-014231
Filing Date
2022-05-13
Accepted
2022-05-13 08:04:58
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tpst-20220331.htm   iXBRL 10-Q 1203343
2 EX-10.1 tpstbradyemploymentagreeme.htm EX-10.1 59063
3 EX-10.2 tpstdubenskyemploymentagre.htm EX-10.2 61154
4 EX-10.3 tpst_samwhitingemploymenta.htm EX-10.3 61173
5 EX-10.4 tpst_nicmaestasemploymenta.htm EX-10.4 64667
6 EX-31.1 exhibit3112.htm EX-31.1 9648
7 EX-31.2 exhibit3122.htm EX-31.2 9575
8 EX-32.1 exhibit3212.htm EX-32.1 6916
  Complete submission text file 0001628280-22-014231.txt   5373342

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpst-20220331.xsd EX-101.SCH 37789
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tpst-20220331_cal.xml EX-101.CAL 48292
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpst-20220331_def.xml EX-101.DEF 166454
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tpst-20220331_lab.xml EX-101.LAB 454145
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpst-20220331_pre.xml EX-101.PRE 304586
63 EXTRACTED XBRL INSTANCE DOCUMENT tpst-20220331_htm.xml XML 629077
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 22920308
SIC: 2834 Pharmaceutical Preparations